Table 2.
Relative expression of CD212 [interleukin (IL)-12Rβ1] and IL-18Rα in both the CD45RBhigh and CD45RBlow within CD4 and CD8 T-cell subsets
| CD4 | CD8 | |||
|---|---|---|---|---|
| CD45RBhigh (95% CI) | CD45RBlow (95% CI) | CD45RBhigh (95% CI) | CD45RBlow (95% CI) | |
| CD212 (IL-12Rβ1) | ||||
| Controls (n = 12) | 10·7 ± 1·59 | 34·6 ± 4·06 | 30·1 ± 3·20 | 50·1 ± 4·12 |
| (7·20–14·3) | (25·5–43·6) | (23·7–38·0) | (40·1–59·2) | |
| CVID (n = 31) | 26·3 ± 5·1 | 42·1 ± 4·06 | 41·8 ± 5·06 | 50·7 ± 4·08 |
| (15·2–37·5) | (33·2–50·1) | (30·7–53·01) | (41·7–59·7) | |
| Asthma (n = 20) | 13·6 ± 2·03 | 29·8 ± 2·54 | 28·9 ± 2·85 | 36·3 ± 3·62 |
| (9·3–17·9) | (24·4–35·2) | (22·4–34·7) | (28·5–44·15) | |
| IL-18Rα | ||||
| Controls (n = 12) | 17·7 ± 1·49 | 48·4 ± 3·21 | 25·7 ± 4·47 | 35·4 ± 3·81 |
| (14·4–21·03) | (41·2–55·6) | (15·6–35·9) | (26·7–44·0) | |
| CVID (n = 31) | 25·7 ± 3·54 | 44·2 ± 3·83 | 21·3 ± 2·64 | 22·6 ± 3·06 |
| (17·9–33·42) | (35·8–52·5) | (15·4–27·1) | (15·9–29·4) | |
| Asthma (n = 20) | 21·3 ± 21·3 | 44·1 ± 2·81 | 25·7 ± 2·84 | 32·3 ± 3·39 |
| (17·8–24·8) | (38·1–50·1) | (19·6–31·8) | (25·0–39·6) | |
CI, confidence interval; CVID, common variable immunodeficiency; n, number of patients.
Data are expressed as mean ± standard error of the mean (95% CI).